INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in UnitedHealth Group Incorporated of Class Action Lawsuit and Upcoming Deadlines - UNH

Core Viewpoint - A class action lawsuit has been filed against UnitedHealth Group Incorporated, alleging securities fraud and unlawful business practices [2][3]. Financial Performance - On April 17, 2025, UnitedHealth reported its Q1 2025 financial results and revised its full-year guidance, lowering its net earnings outlook to a range of $24.65 to $25.15 per share from a previous range of $28.15 to $28.65 per share [3]. - The adjusted earnings outlook was also revised down to a range of $26.00 to $26.50 per share, compared to the earlier guidance of $29.50 to $30.00 per share [3]. - The company indicated that the revised outlook was due to heightened care activity for Medicare Advantage beneficiaries, which exceeded planned increases [3]. Stock Market Reaction - Following the announcement of the revised guidance, UnitedHealth's stock price fell by $159.71 per share, or 27%, closing at $425.33 per share on April 18, 2025 [3].